Institute of Health Carlos III (ISCIII) is a public research institution that promotes, funds, manages and develops excellence biomedical research in Spain. As National Public Health Institute, it is focused on providing support to the Spanish National Health System, through the management and development of scientific knowledge in health sciences, on the promotion and development of an excellent and highly competitive research, as well as on training programs in public health and health management.
Research proposals shall cover the following lines:
Knowledge Area | Centre involved | Overall contents | Investigator in charge and collaborators* | e-mail for contact |
A better knowledge of the diseases prevention, diagnosis and treatment | National Microbioloy Center | Immune Response to sars-covi-2 and pathogenesis of immunological-based diseases. Transmission of COVID-19. Evaluation of vaccines and methodology for vaccines development. Microbiological diagnosis. Serological antibody detection techniques and validation of new PCR kits for diagnosis. Others…tbd | IP: Pepe Alcami | ppalcami@isciii.es |
Epidemiological surveillance and COVID19 risk factors and health determinants research | National Epidemiology Center | Epidemiological surveillance and research of risk factors and health determinant for COVID19. Sero epidemiology of sars-cov-2 and social determinants. Equity Others issues tbd | IP: Marina Pollan. | mpollan@isciii.es |
COVID19 as a Global Health and a intersectorial issue
|
National School of Public Health | Good practices for COVID research. Methodological challenges. Climate change affecting disease behaviour and comorbidity.
International cooperation for better research. COVID Governance. Research dissemination and communication. Social perception of the disease. Others issues tbd
|
IP: Israel Cruz Mata
|
cruzi@isciii.es
|
Copyright © Mujeres por África 2024